سعر دارزالكس 1800 مجم/15 مل فيال تحت الجلد 2024

Darzalex 1800mg/15ml s.c. vial: Daratumumab (Soficopharm).

• Subcutaneous daratumumab product for multiple myeloma as labeled for DARZALEX FASPRO in the US (combination and monotherapy settings per USPI).Population: Adults with multiple myeloma (oncology protocols)DailyMed (U.S. National Library of Medicine)

• Injection-site / systemic administration reactions; same class risks as IV daratumumab including infection and blood-type interference (US FASPRO).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• May cause fetal harm; contraception counseling per US FASPRO label.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Daratumumab: Binds CD38 on myeloma cells and mediates antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and apoptosis.